{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:53:55Z","timestamp":1794020035878,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","award":["No.ZYLX201837"],"award-info":[{"award-number":["No.ZYLX201837"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key R&D Program of China","award":["No. 2017YFC1310103"],"award-info":[{"award-number":["No. 2017YFC1310103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12883-019-1429-9","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T11:03:51Z","timestamp":1566471831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia"],"prefix":"10.1186","volume":"19","author":[{"given":"Cuibai","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihui","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"1429_CR1","unstructured":"Schiffmann R, Fogli A, van der Knaap MS, Boespflug-Tanguy O. Childhood Ataxia with Central Nervous System Hypomyelination\/Vanishing White Matter. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, Amemiya A, editors. Seattle: GeneReviews\u00ae; 1993."},{"issue":"10","key":"1429_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/NEN.0b013e3181f2eafa","volume":"69","author":"M Bugiani","year":"2010","unstructured":"Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS. Leukoencephalopathy with vanishing white matter: a review. J Neuropathol Exp Neurol. 2010;69(10):987\u201396.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1429_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/mrdd.20104","volume":"12","author":"JC Pronk","year":"2006","unstructured":"Pronk JC, van Kollenburg B, Scheper GC, van der Knaap MS. Vanishing white matter disease: a review with focus on its genetics. Ment Retard Dev Disabil Res Rev. 2006;12(2):123\u20138.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"4","key":"1429_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/WNL.48.4.845","volume":"48","author":"MS van der Knaap","year":"1997","unstructured":"van der Knaap MS, Barth PG, Gabreels FJ, Franzoni E, Begeer JH, Stroink H, Rotteveel JJ, Valk J. A new leukoencephalopathy with vanishing white matter. Neurology. 1997;48(4):845\u201355.","journal-title":"Neurology"},{"issue":"3","key":"1429_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ana.410350314","volume":"35","author":"R Schiffmann","year":"1994","unstructured":"Schiffmann R, Moller JR, Trapp BD, Shih HH, Farrer RG, Katz DA, Alger JR, Parker CC, Hauer PE, Kaneski CR, et al. Childhood ataxia with diffuse central nervous system hypomyelination. Ann Neurol. 1994;35(3):331\u201340.","journal-title":"Ann Neurol"},{"issue":"4","key":"1429_CR6","first-page":"167","volume":"26","author":"H Yavuz","year":"2017","unstructured":"Yavuz H. A review of infantile vanishing white matter disease and a new mutation. Acta Neurol Taiwanica. 2017;26(4):167\u201376.","journal-title":"Acta Neurol Taiwanica"},{"issue":"5","key":"1429_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1474-4422(06)70440-9","volume":"5","author":"MS van der Knaap","year":"2006","unstructured":"van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol. 2006;5(5):413\u201323.","journal-title":"Lancet Neurol"},{"issue":"17","key":"1429_CR8","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/WNL.0b013e3181f962ae","volume":"75","author":"HD van der Lei","year":"2010","unstructured":"van der Lei HD, van Berkel CG, van Wieringen WN, Brenner C, Feigenbaum A, Mercimek-Mahmutoglu S, Philippart M, Tatli B, Wassmer E, Scheper GC, et al. Genotype-phenotype correlation in vanishing white matter disease. Neurology. 2010;75(17):1555\u20139.","journal-title":"Neurology"},{"issue":"5","key":"1429_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1086\/379524","volume":"73","author":"MS van der Knaap","year":"2003","unstructured":"van der Knaap MS, van Berkel CG, Herms J, van Coster R, Baethmann M, Naidu S, Boltshauser E, Willemsen MA, Plecko B, Hoffmann GF, et al. eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am J Hum Genet. 2003;73(5):1199\u2013207.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1429_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s00415-006-0306-9","volume":"254","author":"A Riecker","year":"2007","unstructured":"Riecker A, Nagele T, Henneke M, Schols L. Late onset vanishing white matter disease. J Neurol. 2007;254(4):544\u20135.","journal-title":"J Neurol"},{"issue":"6","key":"1429_CR11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1086\/375404","volume":"72","author":"A Fogli","year":"2003","unstructured":"Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R, Boespflug-Tanguy O. Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet. 2003;72(6):1544\u201350.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1429_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/ana.410410515","volume":"41","author":"R Schiffmann","year":"1997","unstructured":"Schiffmann R, Tedeschi G, Kinkel RP, Trapp BD, Frank JA, Kaneski CR, Brady RO, Barton NW, Nelson L, Yanovski JA. Leukodystrophy in patients with ovarian dysgenesis. Ann Neurol. 1997;41(5):654\u201361.","journal-title":"Ann Neurol"},{"issue":"3","key":"1429_CR13","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1111\/j.1468-1331.2008.02395.x","volume":"16","author":"HN Lee","year":"2009","unstructured":"Lee HN, Koh SH, Lee KY, Ki CS, Lee YJ. Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations. Eur J Neurol. 2009;16(3):e42\u20133.","journal-title":"Eur J Neurol"},{"issue":"6","key":"1429_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/archneurol.2011.1942","volume":"69","author":"R La Piana","year":"2012","unstructured":"La Piana R, Vanderver A, van der Knaap M, Roux L, Tampieri D, Brais B, Bernard G. Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation. Arch Neurol. 2012;69(6):765\u20138.","journal-title":"Arch Neurol"},{"issue":"2","key":"1429_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pediatrneurol.2014.05.006","volume":"51","author":"ME Robinson","year":"2014","unstructured":"Robinson ME, Rossignol E, Brais B, Rouleau G, Arbour JF, Bernard G. Vanishing white matter disease in French-Canadian patients from Quebec. Pediatr Neurol. 2014;51(2):225\u201332.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1429_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10048-011-0284-7","volume":"12","author":"T Matsukawa","year":"2011","unstructured":"Matsukawa T, Wang X, Liu R, Wortham NC, Onuki Y, Kubota A, Hida A, Kowa H, Fukuda Y, Ishiura H, et al. Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5. Neurogenetics. 2011;12(3):259\u201361.","journal-title":"Neurogenetics"},{"issue":"7","key":"1429_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s10072-012-1129-3","volume":"34","author":"L Sambati","year":"2013","unstructured":"Sambati L, Agati R, Bacci A, Bianchi S, Capellari S. Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course. Neurol Sci. 2013;34(7):1235\u20138.","journal-title":"Neurol Sci"},{"issue":"20","key":"1429_CR18","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1212\/WNL.0b013e3182749edc","volume":"79","author":"L Ghezzi","year":"2012","unstructured":"Ghezzi L, Scarpini E, Rango M, Arighi A, Bassi MT, Tenderini E, De Riz M, Jacini F, Fumagalli GG, Pietroboni AM, et al. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation. Neurology. 2012;79(20):2077\u20138.","journal-title":"Neurology"},{"issue":"10","key":"1429_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.braindev.2015.03.003","volume":"37","author":"S Shimada","year":"2015","unstructured":"Shimada S, Shimojima K, Sangu N, Hoshino A, Hachiya Y, Ohto T, Hashi Y, Nishida K, Mitani M, Kinjo S, et al. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease. Brain and Development. 2015;37(10):960\u20136.","journal-title":"Brain and Development"},{"issue":"4","key":"1429_CR20","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ajmg.a.36961","volume":"167A","author":"AL Woody","year":"2015","unstructured":"Woody AL, Hsieh DT, McIver HK, Thomas LP, Rohena L. Infantile onset vanishing white matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism. Am J Med Genet A. 2015;167A(4):826\u201330.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"1429_CR21","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1212\/01.WNL.0000123117.11264.0E","volume":"62","author":"H Ohtake","year":"2004","unstructured":"Ohtake H, Shimohata T, Terajima K, Kimura T, Jo R, Kaseda R, Iizuka O, Takano M, Akaiwa Y, Goto H, et al. Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5. Neurology. 2004;62(9):1601\u20133.","journal-title":"Neurology"},{"issue":"Pt 8","key":"1429_CR22","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/brain\/awp171","volume":"132","author":"P Labauge","year":"2009","unstructured":"Labauge P, Horzinski L, Ayrignac X, Blanc P, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, et al. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain. 2009;132(Pt 8):2161\u20139.","journal-title":"Brain"},{"issue":"11","key":"1429_CR23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.neurol.2011.03.008","volume":"167","author":"C Carra-Dalliere","year":"2011","unstructured":"Carra-Dalliere C, Horzinski L, Ayrignac X, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, et al. Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases. Rev Neurol (Paris). 2011;167(11):802\u201311.","journal-title":"Rev Neurol (Paris)"},{"issue":"18","key":"1429_CR24","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1212\/01.wnl.0000260701.76868.44","volume":"68","author":"C Denier","year":"2007","unstructured":"Denier C, Orgibet A, Roffi F, Jouvent E, Buhl C, Niel F, Boespflug-Tanguy O, Said G, Ducreux D. Adult-onset vanishing white matter leukoencephalopathy presenting as psychosis. Neurology. 2007;68(18):1538\u20139.","journal-title":"Neurology"},{"issue":"1","key":"1429_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1468-1331.2007.01999.x","volume":"15","author":"L Peter","year":"2008","unstructured":"Peter L, Niel F, Catenoix H, Jung J, Demarquay G, Petiot P, Rudigoz RC, Boespflug-Tanguy O, Ryvlin P, Mauguiere F. Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor. Eur J Neurol. 2008;15(1):94\u20137.","journal-title":"Eur J Neurol"},{"issue":"6","key":"1429_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/practneurol-2016-001382","volume":"16","author":"RT Ibitoye","year":"2016","unstructured":"Ibitoye RT, Renowden SA, Faulkner HJ, Scolding NJ, Rice CM. Ovarioleukodystrophy due to EIF2B5 mutations. Pract Neurol. 2016;16(6):496\u20139.","journal-title":"Pract Neurol"},{"issue":"6","key":"1429_CR27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.braindev.2014.10.002","volume":"37","author":"K Takano","year":"2015","unstructured":"Takano K, Tsuyusaki Y, Sato M, Takagi M, Anzai R, Okuda M, Iai M, Yamashita S, Okabe T, Aida N, et al. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy. Brain and Development. 2015;37(6):638\u201342.","journal-title":"Brain and Development"},{"key":"1429_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.12688\/f1000research.13933.1","volume":"7","author":"M Humayun","year":"2018","unstructured":"Humayun M, Khan A. Case Report: Cerebral leukodystrophy and the gonadal endocrinopathy: a rare but real association. F1000Res. 2018;7:158.","journal-title":"F1000Res"},{"key":"1429_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4137\/JCNSD.S13540","volume":"6","author":"E Turon-Vinas","year":"2014","unstructured":"Turon-Vinas E, Pineda M, Cusi V, Lopez-Laso E, Del Pozo RL, Gutierrez-Solana LG, Moreno DC, Sierra-Corcoles C, Olabarrieta-Hoyos N, Madruga-Garrido M, et al. Vanishing white matter disease in a spanish population. J Cent Nerv Syst Dis. 2014;6:59\u201368.","journal-title":"J Cent Nerv Syst Dis"},{"issue":"4","key":"1429_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10072-006-0683-y","volume":"27","author":"O Scali","year":"2006","unstructured":"Scali O, Di Perri C, Federico A. The spectrum of mutations for the diagnosis of vanishing white matter disease. Neurol Sci. 2006;27(4):271\u20137.","journal-title":"Neurol Sci"},{"issue":"Pt 1","key":"1429_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1042\/BST0340022","volume":"34","author":"A Fogli","year":"2006","unstructured":"Fogli A, Boespflug-Tanguy O. The large spectrum of eIF2B-related diseases. Biochem Soc Trans. 2006;34(Pt 1):22\u20139.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"1429_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ana.10112","volume":"51","author":"MS van der Knaap","year":"2002","unstructured":"van der Knaap MS, Leegwater PA, Konst AA, Visser A, Naidu S, Oudejans CB, Schutgens RB, Pronk JC. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol. 2002;51(2):264\u201370.","journal-title":"Ann Neurol"},{"issue":"2","key":"1429_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/0883073807308705","volume":"23","author":"J Maletkovic","year":"2008","unstructured":"Maletkovic J, Schiffmann R, Gorospe JR, Gordon ES, Mintz M, Hoffman EP, Alper G, Lynch DR, Singhal BS, Harding C, et al. Genetic and clinical heterogeneity in eIF2B-related disorder. J Child Neurol. 2008;23(2):205\u201315.","journal-title":"J Child Neurol"},{"issue":"2","key":"1429_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/jhg.2008.10","volume":"54","author":"Y Wu","year":"2009","unstructured":"Wu Y, Pan Y, Du L, Wang J, Gu Q, Gao Z, Li J, Leng X, Qin J, Wu X, et al. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease. J Hum Genet. 2009;54(2):74\u20137.","journal-title":"J Hum Genet"},{"issue":"11","key":"1429_CR35","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/0883073812458711","volume":"28","author":"O Unal","year":"2013","unstructured":"Unal O, Ozgen B, Orhan D, Tokatli A, Hismi BO, Dursun A, Coskun T, Kalkanoglu-Sivri HS. Vanishing white matter with hepatomegaly and hypertriglyceridemia attacks. J Child Neurol. 2013;28(11):1509\u201312.","journal-title":"J Child Neurol"},{"issue":"5","key":"1429_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/s-2008-1071551","volume":"24","author":"F Hanefeld","year":"1993","unstructured":"Hanefeld F, Holzbach U, Kruse B, Wilichowski E, Christen HJ, Frahm J. Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics. 1993;24(5):244\u20138.","journal-title":"Neuropediatrics"},{"issue":"9","key":"1429_CR37","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1212\/01.WNL.0000123259.67815.DB","volume":"62","author":"A Fogli","year":"2004","unstructured":"Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, et al. The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology. 2004;62(9):1509\u201317.","journal-title":"Neurology"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1429-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1429-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1429-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T11:38:43Z","timestamp":1721648323000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1429-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1429-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"7 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional review board of Xuan Wu Hospital affiliated to Capital Medical University approved the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the parents of the patient for publication of this case report and accompanying brain MRI images and mutation results. A copy of consent to publish is available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}